Salix inventory issues sink deal with Allergan

November 7, 2014 2:33 AM

13 0

(Reuters) - Salix Pharmaceuticals Ltd slashed its full-year forecast on Thursday and said inventory for its key drugs piled up, an issue that people familiar with the matter said dissuaded Allergan Inc from acquiring the drugmaker.

The two companies were close to inking a deal, but Botox maker Allergan balked after its due diligence raised questions over inventory levels, the people said, requesting anonymity because the negotiations were confidential.

Read more

To category page